| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 170.18 mm | 170.18 mm | 170.18 mm | 170.18 mm | 170.18 mm | 170.18 mm |
| Cash burn (monthly) | (no burn) | 7.12 mm | 22.81 mm | 18.44 mm | 11.09 mm | 13.63 mm |
| Cash used (since last report) | n/a | 19.93 mm | 63.85 mm | 51.63 mm | 31.03 mm | 38.14 mm |
| Cash remaining | n/a | 150.25 mm | 106.33 mm | 118.54 mm | 139.14 mm | 132.03 mm |
| Runway (months of cash) | n/a | 21.1 | 4.7 | 6.4 | 12.6 | 9.7 |
| 13F holders | Current |
|---|---|
| Total holders | 106 |
| Opened positions | 27 |
| Closed positions | 124 |
| Increased positions | 30 |
| Reduced positions | 29 |
| 13F shares | Current |
|---|---|
| Total value | 481.41 bn |
| Total shares | 28.94 mm |
| Total puts | 336.60 k |
| Total calls | 731.10 k |
| Total put/call ratio | 0.5 |
| Largest owners | Shares | Value |
|---|---|---|
| Bill & Melinda Gates Foundation Trust | 6.98 mm | $135.03 bn |
| ARK Investment Management | 2.45 mm | $47.34 bn |
| Shaw David E | 2.40 mm | $0.00 |
| CMTDF Sumitomo Mitsui Trust | 2.16 mm | $41.80 bn |
| Baillie Gifford & Co | 2.12 mm | $41.10 bn |
| STT State Street | 2.12 mm | $40.94 bn |
| MS Morgan Stanley | 1.79 mm | $34.64 bn |
| Lazard Asset Management | 1.34 mm | $25.92 mm |
| Iron Triangle Partners | 1.13 mm | $21.91 bn |
| Parkman Healthcare Partners | 721.37 k | $13.95 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Oct 24 | Margaret Dugan | Common Stock | Sell | Dispose S | No | Yes | 17.783 | 1,531 | 27.23 k | 13,469 |
| 18 Jun 24 | Arun Oberoi | Common Stock | Grant | Acquire A | No | No | 0 | 5,000 | 0.00 | 11,250 |
| 18 Jun 24 | Arun Oberoi | Stock Option Common Stock | Grant | Acquire A | No | No | 19.32 | 8,550 | 165.19 k | 8,550 |
| 18 Jun 24 | Chodakewitz Jeffrey | Common Stock | Grant | Acquire A | No | No | 0 | 5,000 | 0.00 | 11,250 |
| 18 Jun 24 | Chodakewitz Jeffrey | Stock Option Common Stock | Grant | Acquire A | No | No | 19.32 | 8,550 | 165.19 k | 8,550 |
| 18 Jun 24 | Richard Friesner | Common Stock | Grant | Acquire A | No | No | 0 | 5,000 | 0.00 | 515,700 |
| 18 Jun 24 | Richard Friesner | Stock Option Common Stock | Grant | Acquire A | No | No | 19.32 | 8,550 | 165.19 k | 8,550 |
| 18 Jun 24 | Gary Sender | Common Stock | Grant | Acquire A | No | No | 0 | 5,000 | 0.00 | 11,250 |
| 18 Jun 24 | Gary Sender | Stock Option Common Stock | Grant | Acquire A | No | No | 19.32 | 8,550 | 165.19 k | 8,550 |
